Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 11/20 | 0.67 |
| ▸ | MGAM | O43451 | 9/20 | 0.67 |
| ▸ | AMY1A | P0DUB6 | 9/20 | 0.67 |
| ▸ | SI | P14410 | 9/20 | 0.67 |
| ▸ | MGAM2 | Q2M2H8 | 9/20 | 0.67 |
| ▸ | RAB9A | P51151 | 7/20 | 0.67 |
| ▸ | NPC1 | O15118 | 5/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29625506 | 0.84 | GAA (0.73) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL361654 | 0.84 | GAA (0.73) | GAAMGAMAMY1ASIMGAM2 | |
| Hydrochloric Acid SCHEMBL1371916 | 0.83 | GAA (0.71) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL29937880 | 0.83 | GAA (0.67) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL1689837 | 0.83 | GAA (0.67) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL16286769 | 0.83 | GAA (0.67) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL11524883 | 0.83 | GAA (0.67) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL6846939 | 0.82 | EGLN3 (0.68) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL14526175 | 0.81 | RAB9A (0.60) | GAAMGAMAMY1ASIMGAM2 | |
| SCHEMBL17895674 | 0.80 | GAA (0.63) | GAAMGAMAMY1ASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113589662-B | Composition, stripping liquid, application of stripping liquid in stripping of photoresist or photoresist residues and stripping method | 浙江奥首材料科技有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-113589662-A | Composition, stripping liquid, application of stripping liquid in stripping of photoresist or photoresist residues and stripping method | 浙江奥首材料科技有限公司 | 2021-11-02 | — | — | CN | claimed |
| US-8071764-B2 | Compounds of reverse turn mimetics and the use thereof (2) | CHOONGWAE PHARMA CORPORATION (KR) | 2011-12-06 | — | — | US | claimed |
| US-20100228027-A1 | NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) | CHOONGWAE PHARMA CORPORATION (KR) | 2010-09-09 | — | — | US | claimed |
| EP-2212328-A2 | NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) | Choongwae Pharma Corporation (KR) | 2010-08-04 | — | — | EP | claimed |
| WO-2009051398-A2 | NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) | CHOONGWAE PHARMA CORPORATION (KR) | 2009-04-23 | — | — | WO | claimed |
| CN-113589662-B | Composition, stripping liquid, application of stripping liquid in stripping of photoresist or photoresist residues and stripping method | 浙江奥首材料科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-113589662-A | Composition, stripping liquid, application of stripping liquid in stripping of photoresist or photoresist residues and stripping method | 浙江奥首材料科技有限公司 | 2021-11-02 | — | — | CN | disclosed |
| CN-109535158-B | Bisaryl maleimide compound and pharmaceutically acceptable salt thereof, and preparation method and application thereof | 浙江工业大学 | 2021-04-23 | — | — | CN | disclosed |
| EP-2212328-B1 | NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF | CHOONGWAE PHARMA CORP (KR) | 2017-01-25 | — | — | EP | disclosed |
| US-20130289083-A1 | IDO Inhibitors | NEWLINK GENETICS CORPORATION | 2013-10-31 | — | — | US | disclosed |
| US-20130289083-A1 | IDO Inhibitors | NEWLINK GENETICS CORPORATION | 2013-10-31 | — | — | US | disclosed |
| EP-2635275-A1 | GPR17-MODULATING COMPOUNDS, DIAGNOSTIC AND THERAPEUTIC USES THEREOF | Centro Cardiologico Monzino SpA (IT) | 2013-09-11 | — | — | EP | disclosed |
| US-20100144770-A1 | Pyrimidinones as Casein Kinase II (CK2) Modulators | EXELIXIS, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| EP-2074114-A1 | PYRIMIDINONES AS CASEIN KINASE II (CK2) MODULATORS | Exelixis, Inc. (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009051398-A2 | NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) | CHOONGWAE PHARMA CORPORATION (KR) | 2009-04-23 | — | — | WO | disclosed |
| WO-2008143759-A1 | PYRIMIDINONES AS CASEIN KINASE II (CK2) MODULATORS | EXELIXIS, INC. (US) | 2008-11-27 | — | — | WO | disclosed |
| US-20070072833-A1 | Survivin inhibitors | ABBVIE INC. | 2007-03-29 | — | — | US | disclosed |
| US-4329454-A | Cephalosporin compounds | ELI LILLY AND COMPANY (US) | 1982-05-11 | — | — | US | disclosed |
| US-4144391-A | REPLACING AN ACETOXY GROUP BY A SULFUR NUCLEOPHILE | ELI LILLY AND COMPANY (US) | 1979-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072833-A1 | Survivin inhibitors | XIAP, BIRC5, BIRC3 | GAA 1540/4885MGAM 4761/4885AMY1A 4451/4885 |
| US-20100228027-A1 | NOVEL COMPOUNDS OF REVERSE TURN MIMETICS AND THE USE THEREOF (2) | MCL1, BID, MYADM | GAA 3527/4885MGAM 3549/4885AMY1A 4601/4885 |
| US-20130289083-A1 | IDO Inhibitors | IDO1, IDO2, INMT | GAA 1031/4885MGAM 369/4885AMY1A 3625/4885 |
| US-20100144770-A1 | Pyrimidinones as Casein Kinase II (CK2) Modulators | CSNK2A1, CSNK2A2, CSNK1A1 | GAA 1639/4885MGAM 3415/4885AMY1A 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.